SOST and chronic kidney disease: The kidney Wnt/β-catenin pathway signaling showed a significant activation in the CKD+HP group (Figure 3A), which coincided with significantly higher mRNA levels of sclerostin (Sost) and Dickkopf-1 (Dkk1) compared to CKD+NP group (Figure 3B,C).